A double-blind, placebo-controlled study of ketanserin in patients with Prinzmetal's angina. Evidence against a role for serotonin in the genesis of coronary vasospasm.
De Caterina, R
A double-blind, placebo-controlled study of ketanserin in patients with Prinzmetal's angina. Evidence against a role for serotonin in the genesis of coronary vasospasm. [electronic resource] - Circulation May 1984 - 889-94 p. digital
Publication Type: Clinical Trial; Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
0009-7322
10.1161/01.cir.69.5.889 doi
Aged
Angina Pectoris, Variant--drug therapy
Coronary Disease--drug therapy
Coronary Vasospasm--etiology
Double-Blind Method
Drug Evaluation
Hemodynamics--drug effects
Humans
Ketanserin
Male
Middle Aged
Piperidines--adverse effects
Placebos
Platelet Aggregation--drug effects
Serotonin--physiology
Serotonin Antagonists--adverse effects
A double-blind, placebo-controlled study of ketanserin in patients with Prinzmetal's angina. Evidence against a role for serotonin in the genesis of coronary vasospasm. [electronic resource] - Circulation May 1984 - 889-94 p. digital
Publication Type: Clinical Trial; Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
0009-7322
10.1161/01.cir.69.5.889 doi
Aged
Angina Pectoris, Variant--drug therapy
Coronary Disease--drug therapy
Coronary Vasospasm--etiology
Double-Blind Method
Drug Evaluation
Hemodynamics--drug effects
Humans
Ketanserin
Male
Middle Aged
Piperidines--adverse effects
Placebos
Platelet Aggregation--drug effects
Serotonin--physiology
Serotonin Antagonists--adverse effects